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Chronic low-grade inflammation in visceral adipose tissues triggers the development
of obesity-related insulin resistance, leading to the metabolic syndrome, a serious
health condition with higher risk of cardiovascular disease, diabetes, and stroke. In
the present study, we investigated whether Sprouty-related EVH1-domain-containing
protein 2 (Spred2), a negative regulator of the Ras/Raf/ERK/MAPK pathway, plays
a role in the development of high fat diet (HFD)-induced obesity, adipose tissue
inflammation, metabolic abnormalities, and insulin resistance. Spred2 knockout (KO)
mice, fed with HFD, exhibited an augmented body weight gain, which was associated
with enhanced adipocyte hypertrophy in mesenteric white adipose tissue (mWAT)
and deteriorated dyslipidemia, compared with wild-type (WT) controls. The number of
infiltrating macrophages with a M1 phenotype, and the crown-like structures, composed
of macrophages surrounding dead or dying adipocytes, were more abundant in Spred2
KO-mWAT compared to in WT-mWAT. Exacerbated adipose tissue inflammation in
Spred2 KO mice led to aggravated insulin resistance and fatty liver disease. To analyze
the mechanism(s) that caused adipose tissue inflammation, cytokine response in mWAT
was investigated. Stromal vascular fraction that contained macrophages from Spred2
KO-mWAT showed elevated levels of tumor necrosis factor α (TNFα) and monocyte
chemoattractant protein-1 (MCP-1/CCL2) compared with those from WT-mWAT. Upon
stimulation with palmitate acid (PA), bone marrow-derived macrophages (BMDMs)
derived from Spred2 KO mice secreted higher levels of TNFα and MCP-1 than those
from WT mice with enhanced ERK activation. U0126, a MEK inhibitor, reduced the
PA-induced cytokine response. Taken together, these results suggested that Spred2,
in macrophages, negatively regulates high fat diet-induced obesity, adipose tissue
inflammation, metabolic abnormalities, and insulin resistance by inhibiting the ERK/MAPK
pathway. Thus, Spred2 represents a potential therapeutic tool for the prevention of insulin
resistance and resultant metabolic syndrome.
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INTRODUCTION
Metabolic syndrome is characterized by abdominal obesity,
dyslipidemia, elevated blood pressure, and impaired glucose
tolerance. Patients suffering frommetabolic syndrome have twice
the risk of mortality due to cardiovascular disease-associated
events, such as stroke or myocardial infarction, compared with
normal individuals (1). The International Diabetes Federation
(IDF) estimates that one-quarter of the world’s adult population
has metabolic syndrome (2). Thus, metabolic syndrome is a
serious threat to human health.
The principal determinant and core feature of metabolic
syndrome is abdominal obesity (3); although, insulin resistance
has also been recognized as the integral feature of this
syndrome (4). Obesity is associated with a state of chronic,
low-grade inflammation in the adipose tissue, which involves
adipocyte hypertrophy, macrophage infiltration, and adipocyte-
macrophage interaction (5). Saturated fatty acid (SFA) from
hypertrophied adipocytes appears to activate toll-like receptor
(TLR) 4 signaling pathway in adipocytes and macrophages,
resulting in the production of proinflammatory cytokine, tumor
necrosis factor α (TNFα) (6). The absence of TNFα resulted in
significantly enhanced insulin sensitivity in both diet-induced
and leptin-deficient (ob/ob) mouse models of obesity (7). In
addition, the chemokine monocyte chemoattractant protein-1
(MCP-1/CCL2), and its receptor C-Cmotif chemokine receptor 2
(CCR2) play a critical role in macrophage infiltration and insulin
resistance associated with obesity (8, 9).
TNFα activates multiple intracellular signaling pathways,
including the nuclear factor (NF)-κB and the mitogen-activated
protein kinase (MAPK) pathways (10). MCP-1 is also known to
activate MAPK pathway (11). The MAPK family is composed of
the extracellular signal-regulated kinase (ERK)-1/2, c-Jun amino-
terminal kinases (JNKs), and p38 (12). The ERK/MAPK pathway
is crucial in the initiation of the preadipocytes differentiation
(13). Mice lacking ERK1 were resistant to high fat diet (HFD)-
induced obesity and exhibited reduced insulin resistance (14). In
addition, ERK signaling is essential for macrophage development
(15), and stimulation in response to not only lipopolysaccharide
(LPS) (16–18) but also free fatty acid (FFA) (19) via TLR4 (6, 20).
These previous findings suggested that ERK/MAPK is involved
in adipose tissue inflammation and remodeling.
Sprouty-related EVH1-domain-containing protein 2 (Spred2)
is a member of the Spred protein family and inhibits
the Ras/Raf/ERK/MAPK pathway (21). Spred2 ubiquitously
expressed in various tissues including digestive tract, lung,
kidney, and liver (22). As the ERK/MAPK pathway is involved
in several cellular processes in adipocytes or macrophages,
dysregulation of ERK/MAPK signaling could affect diet-
induced obesity and obesity-induced adipose tissue inflammation
and metabolic abnormalities. We previously reported that
Spred2-deficiency in mice exacerbated acetaminophen-induced
hepatotoxicity (23), LPS-induced acute lung inflammation
(17), D-galactosamine/LPS-induced acute liver injury (18), and
polymicrobial septic peritonitis (24). In the present study, we
demonstrate, for the first time, that Spred2 plays an important
role in regulating the development of diet-induced obesity,
obesity-induced adipose tissue inflammation, and metabolic
abnormalities, including fatty liver disease.
MATERIALS AND METHODS
Mice
Spred2 KO mice onto a C57BL/6J background were kindly
provided by Dr. Akihiko Yoshimura (25, 26). The lack of
Spred2 expression in the mesenteric white adipose tissue
(mWAT) and the liver of Spred2 KO mice was confirmed by
TaqMan real-time quantitative polymerase chain reaction (RT-
qPCR) (data not shown). C57BL/6J mice were used as wild-
type (WT) control. WT and Spred2 KO mice were bred and
maintained under continuous 12-h light and 12-h dark cycle
under specific pathogen-free conditions at the Department of
Animal Resources, Okayama University, Okayama, Japan. Male
mice were used in this study. All animal protocols were approved
by the Animal Care and Use Committee of the Okayama
University, and all experiments were performed in accordance
with relevant guidelines and regulations.
Diet-Induced Obesity Model
Mice were weaned from parents at 4 weeks of age and given
free access to water and either the standard diet (SD: 359
kcal/100 g; 12.8% energy as fat; MF, Oriental Yeast Co. Ltd.,
Tokyo, Japan), or high fat diet (HFD: 506 kcal/100 g; 60.0%
energy as fat; HFD-60, Oriental Yeast Co. Ltd.). At different time
intervals, mice were anesthetized, blood was collected by cardiac
puncture, and mWAT and liver were excised. A part of the tissue
was snap-frozen in liquid nitrogen and stored at −80◦C for
subsequent analyses. Another part of the tissue was fixed in 10%
formalin, embedded in paraffin, and thin sections were prepared
and histologically examined. Alternatively, livers were frozen in
O.C.T compound and cryostat sections were stained by oil red O
as per the standard techniques. In another set of experiments, a
whole mWAT was resected and used for isolation of adipocytes
and stromal vascular fraction as described below.
Micro-Computed Tomography (Micro-CT)
Image Acquisition
Mice (20 weeks of age) were anesthetized with isoflurane
(Mylan Inc., Canonsburg, PA, USA) and scanned by micro-CT
(LaTheta LCT-200; Hitachi Aloka Medical, Ltd., Tokyo, Japan).
The abdominal adiposity was assessed using image-analyzing
software (LaTheta v1.20).
Blood Analysis
Serum total cholesterol, triglyceride, and blood glucose
concentrations were measured using standard protocols. The
serum insulin concentrations were measured using an insulin
assay kit (Morinaga Institute of Biological Science Inc., Tokyo,
Japan). The serum FFA concentrations were measured using
a LabAssay NEFA kit (Wako Pure Chemical Industries Inc.,
Osaka, Japan).
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Glucose and Insulin Tolerance Tests
After 16 weeks of feeding (20 weeks of age), glucose and insulin
tolerance tests were conducted by intraperitoneally injecting
glucose (1 g/kg body weight, Sigma-Aldrich, St. Louis, MO, USA)
and insulin (1 U/kg body weight, Eli Lilly Japan K.K., Hyogo,
Japan), respectively, as previously described (27). Blood was
sampled from the tail vein of mice, and blood glucose level was
evaluated using a blood glucose test meter (Lab Gluco: ForaCare
Suisse AG, St. Gallen, Switzerland).
Isolation of Adipocytes and Stromal
Vascular Fraction (SVF)
mWAT was minced and digested using type II collagenase
(Sigma-Aldrich) dissolved in PBS at 37◦C for 20min on an orbital
shaker. The digested tissues were centrifuged at 500 × g for
10min. The pelleted cells represented the SVF, and the floating
cells represented the adipocyte fraction (28).
Isolation and Culture of Bone
Marrow-Derived Macrophage (BMDM)
Bone marrow (BM) was harvested from the femur and tibia
of WT or Spred2 KO mice. For generation of BMDMs, BM
cells were cultured in RPMI-1640 medium, supplemented with
10% FBS and antibiotics, in the presence of M-CSF (50 ng/ml,
PeproTech, Inc., Rocky Hill, NJ, USA) for 7 days. Adherent
BMDMswere collected and plated onto 24-well plates at a density
of 5× 105 cells per well. Cells were incubated overnight in serum-
free RPMI-1640 medium, and then stimulated by bovine serum
albumin (BSA)-conjugated palmitic acid (PA, 500µM, Cayman
chemical, Ann Arbor, MI, USA) for 24 h. BSA-conjugated PA
was prepared as previously described (29) with modifications. In
another set of experiments, BMDMswere pre-treated withU0126
(10µM, Promega, Madison,WI, USA) or vehicle (DMSO) for 1 h
and then cultured with BSA-conjugated PA for 24 h.
Adipocyte Differentiation
3T3-L1 preadipocytes (American Type Culture Collection)
were cultured in DMEM containing 10% FBS and antibiotics.
Differentiation of 3T3-L1 preadipocytes to mature adipocytes
was performed, as described (30). Adipocyte differentiation was
determined by oil red O staining.
Short-Interfering (si) RNA and Plasmid
Transfection
A total of 1 × 106 adipocytes differentiated from 3T3-
L1 preadipocytes at day 8 were transfected with Spred2-
specific or non-targeting control siRNAs (final concentration 5
pmol; Thermo Scientific, Yokohama, Japan) (17, 31) using a
Lipofectamine RNAiMAX (Thermo Scientific) according to the
manufacturer’s instructions and plated in a 24-well plate. For
plasmid transfections, BMDMs were seeded into 24-well plate
at a density of 2 × 105 cells per well and incubated overnight
in a 5% CO2 incubator at 37
◦C. For each transfection, 0.75
µL Lipofectamine 3000 (Life Technologies, Carlsbad, CA, USA)
and 0.5 µg Spred2 expression plasmid (kindly provided by Dr.
Masakiyo Sakaguchi, Okayama university, Japan) were added to
50 µL Opti-MEM (Life Technologies) and incubated for 10min
at room temperature before the mixtures were added to the
cells. Cells that overexpressed Spred2 were grown in RPMI-
1640 medium with 10% FBS for 24 h. Cells were then incubated
overnight in serum-free RPMI-1640 medium, after which the
cells were cultured with BSA-conjugated PA (500µM) for 24 h.
Lipolysis Assay and Fatty Acid (FA) Uptake
Assay
Epididymal fat pads were minced and digested using type II
collagenase (Sigma-Aldrich) dissolved in PBS at 37◦C for 20min
on an orbital shaker. The digested tissues were centrifuged at
280 × g for 5min. The infranatant containing the collagenase
solution was removed, and the floating layer of adipocytes was
washed three times with PBS. For lipolysis assay, aliquots of
isolated adipocytes were incubated in the absence or presence of
100 ng/ml TNFα (R&D systems Inc., Minneapolis, MN, USA) for
3 h. Glycerol content in the infranatant medium was measured
using a glycerol colorimetric assay kit (Cayman chemical).
To investigate FA uptake, isolated adipocytes were incubated
with 20µM BODIPY FL C16 (Thermo Scientific) in DMEM
containing 1%FA-free BSA (Sigma) in the absence or presence
of 100 nM insulin (Takara Bio Inc., Shiga, Japan) for 1 h. After
the transport period, cells were washed with PBS and then
lysed in 0.05N NaOH (32). Fluorescence intensity was measured
using FlexStation 3 multi-mode microplate reader (Molecular
Devices, LLC. San Jose, CA, USA) at Ex 503 and Em 512 nm, and
normalized to intra-droplet fluorescence intensity.
Histological Analyses
mWAT paraffin sections were stained with hematoxylin and
eosin, and the adipocyte size was assessed using the NIH’s ImageJ.
For immunohistochemistry, sections were incubated with either
10µg/ml of rat anti-F4/80 antibody (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA), 2µg/ml of rabbit anti-iNOS antibody
(Abcam plc., Cambridge, MA, USA), or 10µg/ml of rat anti-
CD206 antibody (Bio-Rad) for 90min, followed by incubation
with either Polink-2 Plus HRP Rat-NM with DAB kit or Polink-
2 Plus HRP Rabbit with DAB kit (GBI, Inc., Bothell, WA,
USA) according to the manufacturer’s instructions. Antigen
was visualized using 3,3′-diaminobenzidine substrate (Sigma-
Aldrich).
RT-qPCR
Total RNA was extracted from mWAT, adipocytes, or SVF
using TRIsure reagent (Bioline Reagents Ltd., London,
UK). cDNA was synthesized by the High Capacity cDNA
Reverse Transcription Kit (Thermo Scientific) using 500
ng of total RNA. RT-qPCR was performed using StepOne
Plus Real-Time PCR system with Taqman PCR master mix
(Thermo Scientific). The primers used in this study were:
Spred2 (Mn01223872_g1), tnfa (Mm00443258_m1), mcp-1
(Mm00441242_m1), adiponectin (Mm00456425_m1), leptin
(Mm00434759_m1), pai1 (Mm00435858_m1), and rplp0
(Mm00725448_s1) (Thermo Scientific). The expression level of
the gene of interest was normalized against rplp0 and expressed
as fold-increases relative to the negative control for each
treatment at each time point as previously described (17, 33).
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Western Blotting
Cells were lysed using a lysis buffer (Cell Signaling Technology
Inc., Danvers, MA, USA). After centrifugation, clear
supernatants were collected and stored at −80◦C until further
use. The protein concentration in the lysates was measured
using protein-dye binding assay (Bio-Rad). Equal amounts
(15 µg) of cell lysates were fractionated using sodium dodecyl
sulfate–polyacrylamide (SDS) gel electrophoresis (Thermo
Scientific), and then proteins were transferred to nitrocellulose
membrane. After blocking with TBS-T (Tris-buffered saline
containing 0.1% Tween-20) containing 5% BSA, the membranes
were incubated with an antibody against either phosphorylated
ERK or total ERK (Cell Signaling Technology Inc.) overnight.
After washing with TBS-T, membranes were incubated with
horseradish peroxidase-conjugated anti-rabbit IgG antibody
(Cell Signaling Technology Inc.), and each protein present on the
membrane was visualized using an enhanced chemiluminescence
system (ImmunoStar LD; Wako Pure Chemical Industries Inc.).




The concentration of TNFα or MCP-1 was measured using a
standard sandwich ELISA, as previously described (34, 35). The
primary antibody, detection antibody, and recombinant TNFα
and MCP-1 were purchased from R&D Systems. The ELISAs
used in this study did not cross-react with other known murine
cytokines.
Statistics
All data were expressed as the mean ± SEM. Data were analyzed
using the GraphPad Prism software (GraphPad Software, San
Diego, CA). Student’s t-test and analysis of variance (ANOVA)
were performed to determine the statistical significance. P-values
smaller than 0.05 were considered significant.
RESULTS
Enhanced Diet-Induced Obesity in Spred2
KO Mice
We first compared the weights of WT and Spred2 KO mice
fed with SD. Spred2 KO mice exhibited increased body weight
compared to WT mice (Figure 1A). Since HFD leads to obesity,
particularly in C57BL/6J background (36, 37), we next fed WT
and Spred2 KO mice with HFD and examined their weights.
As shown in Figure 1A, HFD led to increased body weight
in both WT and Spred2 KO mice; however, Spred2 KO mice
gained significantly more weight than WT mice (27% heavier)
than WT mice after 20 weeks. No difference was found in food
consumption between the groups (Figure 1B). There was also
no significant difference in the body length between the two
strains. CT images demonstrated increased mass of abdominal
fat in Spred2 KO mice than in WT mice (Figure 1C). mWATs
were subsequently weighed after 16 weeks of SD orHFD.mWATs
of Spred2 KO mice were heavier than those of WT mice, when
fed with either SD or HFD (Figure 1D). These results clearly
indicated that Spred2-deficiency enhanced diet-induced obesity.
Enhanced Adipocyte Hypertrophy and
Dyslipidemia in Spred2 KO Mice
Obesity is associated with dynamic adipose tissue remodeling
characterized by adipocyte hypertrophy (38, 39). As shown
in Figures 2A,B, the size of adipocytes in mWAT increased
with age (in weeks) in HFD-fed WT and Spred2 KO mice.
The size of adipocytes in Spred2 KO-mWAT was significantly
larger than that in WT-mWAT, especially after 16 weeks of
HFD (Figure 2B). The distribution of adipocyte size shifted
toward larger size in Spred2 KO-mWAT after 16 weeks of HFD
(Figure 2C).
HFD may affect the level of Spred2 mRNA expression in
mWAT. As shown in Figure 2D, Spred2 mRNA expression
in WT-mWAT significantly decreased when fed with HFD
compared to SD. Next, the serum lipid concentration was
measured (Figure 2E). HFD caused an elevation in serum levels
of total cholesterol and triglycerides at the age of 20 weeks.
FFA levels in HFD-Spred2 KO mice were also significantly
higher than those in WT mice after 8 weeks of HFD and
remained elevated after 16 weeks of HFD (Figure 2F). Thus,
over-nutrition caused by HFD exacerbated dyslipidemia in
Spred2 KO mice.
FIGURE 1 | Enhanced diet-induced obesity in Spred2 KO mice. WT and
Spred2 KO mice were fed ad libitum with either a standard diet (SD) or a
high-fat diet (HFD) from 4 to 20 weeks of age. (A) Body weight of WT and
Spred2 KO mice. 1, SD-WT; N, SD-Spred2KO; ◦, HFD-WT; •, HFD-Spred2
KO. **p < 0.01 (6 mice each group). (B) SD-food intake of WT () and Spred2
KO () mice. Data are shown as average food intake per day from 4 to 6
weeks of age (6 mice each group). (C) Representative appearance (left) and
computed tomography (CT) image (right; blue, intestine; purple, abdominal
adipose tissue) of HFD-fed WT and Spred2 KO mice at the age of 20 weeks.
(D) The weight of mWATs of SD—or HFD-fed WT () or Spred2 KO mice ().
**p < 0.01 (SD: 4 mice each group, HFD: 6 mice each group).
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FIGURE 2 | Enhanced adipocyte hypertrophy and dyslipidemia in Spred2 KO
mice. WT and Spred2 KO mice were fed with HFD from 4 to 20 weeks of age.
Mice were euthanized at 12 weeks or 20 weeks, and mWATs were resected at
the time of sacrifice. (A) Representative hematoxylin and eosin (H&E) staining
sections (scale bar, 100µm). Crown-like structure is indicated by arrow heads.
(B) Adipocyte size in mWAT from WT () or Spred2 KO () was measured.
**p < 0.01 (6 mice each group). (C) The distribution of adipocyte size at 20
weeks of age. (D) mRNA expression of Spred2 in mWATs of WT mice fed with
SD or HFD at 20 weeks of age were analyzed by RT-qPCR. The expression
levels of Spred2 mRNA were normalized to that of rplp0. **p < 0.01 (6 mice
each group). The samples harvested at 4 weeks of age were used as baseline
controls. (E) Serum levels of total cholesterol and triglyceride from WT () and
Spred2 KO () mice fed with HFD at 20 weeks of age were measured.
*p < 0.05 (6 mice each group). Dotted line represents data from mice fed with
SD from 4 to 20 weeks (mean from 4 mice). (F) Serum levels of free fatty acid
(FFA) from WT mice () and Spred2 KO mice () were measured. **p < 0.01
(6 mice each group). Dotted line represents data from mice fed with SD from 4
to 20 weeks (mean from 4 mice).
Exacerbated Adipose Tissue Inflammation
in Spred2 KO Mice
Dyslipidemia may lead to low-grade inflammation,
characterized by macrophage infiltration in adipose tissue
(40). Immunohistochemical analyses revealed that the number of
F4/80 positive macrophages (Figure 3A) in Spred2 KO-mWAT
was significantly higher than that in WT-mWAT (Figure 3B,
left). Crown-like structures, composed of macrophages
surrounding dead or dying adipocytes (Figure 3A) (41),
were significantly increased in Spred2 KO-mWAT (Figure 3B,
right). Macrophages migrating in mWAT are known to
have M1 phenotype (pro-inflammatory macrophages) (42).
FIGURE 3 | Exacerbated adipose tissue inflammation in Spred2 KO mice. WT
and Spred2 KO mice were fed with HFD from 4 to 20 weeks of age. Mice were
euthanized at 12 weeks or 20 weeks, and mWATs were resected at the time of
sacrifice. (A) Macrophages were stained with anti-F4/80 Ab (original scale bar,
100µm). Representative results from 6 mice are shown. Crown-like structure
(CLS) is indicated by arrow heads. (B) The number of F4/80+ cells and
F4/80+ CLS was counted at 20 weeks of age. , WT; , Spred2 KO.
**p < 0.01 (6 mice each group). (C) Macrophages were stained with anti-iNOS
Ab (original scale bar, 100µm). Representative results from six mice are
shown. (D) The number of iNOS+ CLS (arrow heads) was counted at 20
weeks of age. , WT; , Spred2 KO. **p < 0.01 (6 mice each group).
Consequently, we performed immunostaining using antibodies
against either inducible nitric oxide synthase (iNOS) or CD206,
known representative markers for M1 or M2, respectively,
(43). The number of iNOS+ macrophages (Figure 3C) was
significantly higher in Spred2 KO-mWAT than that in WT-
mWAT (Figure 3D), whereas there were only a few CD206+
macrophages in both groups and M1:total macrophage ratio was
similar between both groups (data not shown). These results
suggested that Spred2 KOmice exhibited exacerbated infiltration
of pro-inflammatory macrophages.
Impaired Insulin Resistance and Fatty Liver
Disease in Spred2 KO Mice
Obesity-induced adipose tissue inflammation leads to insulin
resistance (4, 44, 45). As shown in Figure 4A, serum levels
of glucose in Spred2 KO mice were significantly higher than
those in WT mice, although the insulin levels were similar
between the groups. Consequently, in vivo metabolic tests were
performed, which showed that both glucose intolerance and
insulin resistance were aggravated in Spred2 KO mice when
compared with WT mice (Figures 4B,C). Thus, Spred2 KO mice
showed impaired insulin resistance.
The liver plays a principal role in lipid metabolic pathways.
Increased serum lipid levels and impaired insulin resistance
may cause non-alcoholic fatty liver disease (NAFLD)/non-
alcoholic steatohepatitis (NASH) (46) in Spred2 KO mice. The
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FIGURE 4 | Impaired insulin resistance in Spred2 KO mice. WT and Spred2
KO mice were fed with HFD from 4 to 20 weeks of age. (A) Mice were
euthanized at 20 weeks, and serum levels of glucose and insulin were
measured. **p < 0.01 (6 mice each group). Dotted line represents data from
mice fed with SD from 4 to 20 weeks (mean from 4 mice). (B,C). Blood
glucose levels after intraperitoneal injection of (B) glucose (1 g/kg body weight)
or (C) insulin (1 U/kg body weight) were measured at 20 weeks of age.
Percent changes are shown in (C). ◦, WT; •, Spred2 KO. *p < 0.05,
**p < 0.01 (6 mice each group).
expression of Spred2 in WT-livers tended to increase when
mice were fed with HFD (p = 0.12, Figure 5A). The data
in Figure 5B demonstrated that HFD-Spred2 KO-livers were
heavier than WT-livers. Histologically, in comparison with WT-
livers, Spred2 KO-livers revealed moderate vesicular steatosis,
and influx of neutrophils and F4/80-positive macrophages.
Perivenular/pericellular fibrosis was not evident by Masson’s
trichrome staining (Figure 5C). The serum levels of ALT, a
marker of liver injury, tended to increase in Spred2 KO mice
as compared with WT mice (p = 0.14, after 16 weeks of HFD,
Figure 5D). These data indicated that Spred2 KOmice developed
NAFLD/NASH.
Enhanced Cytokine Response in Spred2
KO Mice
Macrophage infiltration in mWAT can be induced by cytokines,
among which TNFα and MCP-1 appear to be crucial (47, 48).
To examine the cytokine response, we examined the expression
of TNFα and MCP-1 mRNA in mWATs obtained from mice fed
with HFD. After 16 weeks of HFD, mRNA levels of TNFα and
MCP-1 in Spred2 KO-mWAT tended to be higher than those in
WT-mWAT (Figure 6A), although the data was not statistically
significant (TNFα; p = 0.43, MCP-1; p = 0.10). Next, mWATs
were divided into adipocytes and stromal vascular fraction (SVF)
that contained preadipocytes, endothelial cells, and macrophages
(49), and the cytokine responses of both fractions were examined.
As shown in Figure 6B, expression levels of TNFα and MCP-1
were 2.2-fold and 3.1-fold higher in Spred2 KO-SVF, respectively,
than those in WT-SVF. The expression level of TNFα was
higher in Spred2 KO-adipocytes than that in WT-adipocytes,
but its expression level was lower than that in the SVF. No
difference was found in the expression levels of adipocyte-
MCP-1 between the mouse groups (Figure 6B). Interestingly,
expression of circulating MCP-1/CCL2 tended to be higher
in Spred2 KO mice than that in WT mice (p = 0.09),
despite no detection of TNFα in either group (Figure 6C).
The levels of other adipokines, including adiponectin, leptin,
and plasminogen activator inhibitor-1 (PAI-1) in the adipocytes
were similar between the groups, although, a decreasing trend
was observed in the levels of adiponectin (p = 0.14, 6 mice
each, Supplementary Data 1). These results suggested that SVF
preferentially plays an important role in the regulation of adipose
tissue inflammation by generating TNFα and MCP-1.
Cytokine Production and Lipid Metabolism
in Spred2 Deficiency
Spred2 in adipocytes may regulate cytokine production and lipid
metabolism. For cytokine production, we knocked down Spred2
expression (∼80% reduction) in adipocytes differentiated from
3T3-L1 preadipocytes using short interfering (si)RNA and the
cells were stimulated with TNFα (10 ng/ml) for 24 h. Spred2
knockdown did not alter the expression levels of de novo
TNFα and MCP-1 as compared to the controls (data not
shown), suggesting that the role of Spred2 in adipocyte cytokine
production is minimal. For lipid metabolism, we compared
glycerol release and fatty acid uptake between primary WT-
and Spred2 KO-adipocytes. No difference was found in the
glycerol release (WT vs. Spred2 KO, 3.12 ± 0.07 vs. 3.42 ±
0.24 mg/l/106 cells, n = 4 each, not significant) and fatty
acid uptake (WT vs. Spred2 KO, 1.20 ± 0.20 vs. 1.32 ±
0.26/normalized fluorescence, n = 4 each, not significant)
between the groups after the stimulation with TNFα and
insulin, respectively. To examine the involvement of Spred2 in
adipocyte hypertrophy, we knocked down Spred2 expression
(∼80% reduction) in adipocytes differentiated from 3T3-L1
preadipocytes and cultured for 21 days. After oil red O staining,
adipocyte hypertrophy was quantified by extracted oil red O
level. Spred2 knockdown did not alter the amount of lipid
contents (control vs. Spred2 knockdown, 0.52 ± 0.02 vs. 0.49 ±
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FIGURE 5 | Exacerbated fatty liver disease in Spred2 KO mice. (A) WT mice were fed with either SD or HFD (6 mice each group) from 4 to 20 weeks of age. Livers
were resected at 20 weeks of age and Spred2 mRNA expression was quantitated. The expression levels of Spred2 mRNA were normalized to that of rplp0. The
samples harvested at 4 weeks of age were used as baseline controls. (B–D) WT and Spred2 KO mice were fed with HFD from 4 to 20 weeks of age. (B) The livers
were resected at 20 weeks of age. Upper panel, a representative gross appearance of the liver from WT or Spred2 KO mice was shown. Lower panel, the livers were
weighed. **p < 0.01 (6 mice each group). (C) The liver tissues at 20 weeks of age were stained with H&E, Oil Red O, for F4/80 (immunostaining), or Masson’s
trichrome (scale bar, 50µm). Circle area; neutrophil infiltration. Representative photos from each group were shown (6 mice each group). (D) Serum ALT levels were
measured at 12 and 20 weeks. ◦WT, •KO (6 mice each group, each time point).
0.07/absorbance at 490 nm, n = 3 each, not significant). These
data suggest that Spred2 in adipocytes does not play a significant
role in cytokine production and lipid metabolism.
Involvement of ERK/MAPK in Macrophage
Cytokine Response
We hypothesized that macrophages, a major structural
component of SVF, are the main cells involved in the production
of cytokines. To confirm the role of macrophages in mWAT,
we employed bone marrow-derived macrophages (BMDMs),
as majority of adipose tissue macrophages are derived from
the bone marrow (50). Upon stimulation of macrophages with
SFA (palmitic acid; PA), Spred2 KO-macrophages produced
significantly higher levels of TNFα and MCP-1 than WT-
BMDMs (Figure 7A). However, pretreatment with U0126,
a selective MEK/ERK inhibitor, significantly reduced the
production of TNFα and MCP-1 in both WT-and Spred2
KO-macrophages (Figure 7A), suggesting that the cytokine
response was dependent on the ERK/MAPK pathway. In
addition, the phosphorylation of ERK was significantly enhanced
in Spred2 KO-macrophages compared to WT-macrophages after
PA-stimulation (Figure 7B, left). The phosphorylation of ERK
in WT-macrophages returned to the basal level by 4 h, whereas
levels of ERK phosphorylation remained elevated in Spred2
KO-macrophages (Figure 7B, right). Thus, macrophages appear
to be responsible for the enhanced production of TNFα and
MCP-1 in absence of Spred2.
Spred2 Overexpression Reduced Cytokine
Responses in Macrophages
The above data raised the question of whether greater amounts
of Spred2 in a cell could reduce cytokine responses. To address
this, we overexpressed Spred2 in WT-macrophages using an
overexpression plasmid that increased Spred2 expression by 90-
fold, as determined by Taqman RT-qPCR (data not shown).
Although no difference was found in the level of TNFα,
Spred2 overexpression significantly reducedMCP-1 level after PA
stimulation compared with the control cells (Figure 8). Thus,
Spred2 overexpression effectively reduced PA-induced MCP-1,
but not TNFα response. Endogenous Spred2 in macrophages
may be sufficient to down-regulate TNFα response.
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FIGURE 6 | Enhanced cytokine response in Spred2 KO mice. WT and Spred2
KO mice were fed with HFD from 4 to 20 weeks of age, and euthanized at 20
weeks of age. (A) mWATs were resected and mRNA expression of TNFα (left)
and MCP-1 (right) was quantitated. The expression levels of Spred2 mRNA
were normalized to that of rplp0. ◦, WT; •, Spred2 KO. (B). mWATs were
divided into adipocytes and stromal vascular fraction (SVF), and mRNA
expression of TNFα (left) and MCP-1 (right) were quantitated. The expression
levels of each mRNA were normalized to that of rplp0. , WT; , Spred2 KO.
*p < 0.05, **p < 0.01, ***p < 0.001 (6 mice each group). (C) Serum levels of
TNFα and MCP-1 (8 mice each group) were measured., WT;, Spred2 KO.
DISCUSSION
Previous studies have shown that the MAPK pathway, especially
the ERK/MAPK pathway plays an important role in obesity
and obesity-associated insulin resistance (13, 51). Genome-
wide association studies have indicated that a genetic variation
near the Sprouty homolog 2 (SPRY2) gene, an inhibitor of
the Ras/Raf/ERK/MAPK pathway (52), is associated with body
fat percentage in human (53, 54). In the present study, we
explored the role of Spred2 in obesity and obesity-associated
systemic responses, and found that Spred2 KO mice developed
exacerbated obesity, hyperlipidemia, hyperglycemia, insulin
resistance, and fatty liver upon feeding with HFD, reflecting a
severe state of metabolic syndrome. Thus, for the first time, we
identified Spred2 as an important molecule that regulates obesity
and obesity-associated metabolic abnormalities.
It has been shown that ERK1 KO mice have decreased
adiposity and fewer adipocytes than WT mice and are resistant
FIGURE 7 | The involvement of ERK/MAPK in macrophage cytokine
response. BM cells were harvested from WT and Spred2 KO mice and
differentiated into BMDM. (A) Macrophages from WT () or Spred2 KO ()
mice were stimulated with palmitate acid (PA) (500 nM) with or without U0126
(10µM) treatment for 24 h. Cytokine levels in the culture supernatants were
measured by ELISA. *p < 0.05, **p < 0.01 (3 samples each group).
(B) Macrophages from WT () or Spred2 KO () mice were stimulated with
PA for 2 and 4 h. Left, immunoblot data from three independent experiments.
Right, the density of each band was digitalized and semi-quantitated.
*p < 0.05, **p < 0.01, ***p < 0.001 (3 samples each group, each time point).
FIGURE 8 | Spred2 overexpression reduced cytokine responses in
macrophages. Spred2 was overexpressed by transfecting macrophages with
mixtures of Lipofectamine 3000 and Spred2 overexpression plasmid and
control plasmid for 24 h, after which the cells were stimulated with PA (500µM)
for 24 h. Cytokine levels in the culture supernatants were measured by ELISA.
**p < 0.01 (4 samples each group).
to obesity induced by HFD (14). The ERK/MAPK pathway is
crucial for the differentiation of 3T3-L1 cells into adipocytes
(55). Inhibition of the ERK/MAPK pathway in 3T3-L1 adipocytes
by MEK inhibitors ameliorated the adipokine expression and
suppressed the lipolytic activity (56). TNFα-induced lipolysis
was inhibited by U0126 or PD98059, a selective MEK/ERK
inhibitors, in 3T3-L1 adipocytes (57). Thus, ERK/MAPK appears
to be involved in adipocyte hypertrophy and lipolysis. We
demonstrated in this study that the Spred2 KOmice exhibited an
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exacerbated level of adipocyte hypertrophy and hyperlipidemia
(elevated levels of cholesterol, triglyceride, and FFA), suggesting
that Spred2 negatively regulates adipocyte hypertrophy and
hyperlipidemia.
Interestingly, Spred2 expression in WT-mWATs was
dramatically reduced by HFD, although the expression was
increased in the liver. When BMDMs were stimulated with
PA, Spred2 expression was significantly reduced whereas
the expression was increased when adipocytes differentiated
from 3T3-L1 preadipocytes were stimulated with TNFα
(Supplementary Data 2). These data represent the unique
behavior of Spred2 expression in different tissues and cell-types.
It remains unclear how HFD decreases the Spred2 expression in
WT-mWAT; however, HFD may drive epigenetic changes that
result in Spred2 gene regulation. Further studies will be necessary
to identify the precise molecular mechanisms involved.
Various inflammatory mediators are involved in adipose
tissue inflammation. Among them, a paracrine loop linking
fatty acids, TNFα, and MCP-1 establish a vicious cycle between
adipocytes and macrophages that aggravates inflammation in
the adipose tissues (47). TNFα and MCP-1 are adipokines (48)
and are also produced from macrophages. Fatty acids released
from the hypertrophied adipocytes appear to preferentially
stimulate macrophages to produce TNFα and MCP-1, as levels
of TNFα and MCP-1 in Spred2 KO-SVF were significantly
higher compared to adipose tissues. In addition, Spred2 KO-
macrophages expressed increased levels of TNFα and MCP-1
upon stimulation with SFA (PA). Spred2 knockdown did not
alter TNFα and MCP-1 levels in 3T3-L1 adipocytes. Thus, our
data suggested the involvement of macrophages rather than
adipocytes in enhanced TNFα and MCP-1 expression in Spred2
KO mice.
Spred2 deficiency may have a more direct effect on adipocyte
fat accumulation and/or lipolysis. However, lipid metabolism,
as assessed by glycerol release and fatty acid uptake, was
unchanged between WT-and Spred2 KO-adipocytes, and Spred2
knockdown failed to alter 3T3-L1 adipocyte hypertrophy.
Cytokine, especially TNFα, is known to release FFA from
adipocytes. Although Spred2 KO mice have increased fat mass
under SD treatment, there was no apparent adipose tissue
inflammation and dyslipidemia (data not shown). It is possible
that augmented inflammation in Spred2 deficiency under HFD
affect adipose tissue pathology via upregulated cytokine response
by macrophages. Additional study is required to obtain more
definitive answers.
To determine the contribution of Spred2 in macrophages,
we employed bone marrow chimeric mice, and examined their
weights and performed glucose and insulin tolerance tests after
being fed on HFD; however, no significant differences were
found between the groups (Supplementary Data 3), likely due
to the adipose tissue alteration to radiation exposure (58).
Irradiation could alter the properties of adipocytes. Conditional
macrophage—or adipocyte-specific Spred2 may reveal such
mechanisms in detail. Macrophage response could be mediated
through TLR4 (6, 20). The TLR4 ligand LPS stimulated bone
marrow-derived macrophages to produce TNFα and MCP-1
(17). We recently showed that macrophage cytokine response
to LPS was partially blocked by U0126 (24), suggesting that
Spred2 may be involved in the regulation of the MAPK pathway
downstream of TLR4. It is also possible that Spred2 may suppress
TLR signaling by other unidentified mechanisms.
Spred2 deficiency resulted in fatty liver hepatitis without
liver fibrosis. Previous studies have revealed that HFD-fed mice
developed liver fibrosis after 9.5 months (59) or 1 year (60),
suggesting a possibility that Spred2 KOmice may develop NASH
with liver fibrosis after being fed for a long period of HFD.
Further studies are necessary to investigate the contribution
of Spred2 in development of NAFLD/NASH, and subsequent
hepatocellular carcinoma.
In conclusion, we showed that Spred2-deficiency promotes
obesity, adipose tissue inflammation, and insulin resistance,
possibly via enhanced adipose tissue inflammation caused by
enhanced macrophage activation. A fascinating question is
whether the abnormal metabolic status induced by high calorie
diet can be treated by Spred2 supplementation in vivo. Spred2
may act as a novel therapeutic tool to treat the progression of
pathophysiology associated with metabolic syndrome.
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